companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories














  • BioNTech
    BioNTech guides you through the promising world of immunotherapies Find information on basic research and new developments of new treatment options
  • BioNTech - Wikipedia
    BioNTech SE ( biːˈɒntɛk bee-ON-tek; or baɪˈɒntɛk bye-ON-tek[3] short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases
  • BioNTech to wind down cell therapy manufacturing in Maryland
    Following a disappointing performance from the company’s CAR-T candidate in an early-stage cancer trial, BioNTech is winding down cell therapy manufacturing at its inaugural U S plant
  • BioNTech Completes Acquisition of Biotheus | BioNTech
    Biotheus will operate as a new indirect Chinese subsidiary of BioNTech, adding a local research and development hub and an advanced biologics manufacturing facility to the Company’s network
  • BioNTech Clinical Trials | Advancing Health Through Innovation
    Discover how BioNTech is pioneering novel medicines for cancer and infectious diseases Learn more about our clinical trials, the importance of participation, and how to get involved in advancing global health
  • Bristol Myers agrees up to $11. 1 billion deal with BioNTech to shake up . . .
    June 2 (Reuters) - Bristol Myers Squibb (BMY N) has agreed to pay up to $11 1 billion to partner with Germany's BioNTech and develop the latter's next-generation cancer immunotherapy, which could
  • BioNTech: More Uncertainty Emerges - Seeking Alpha
    BioNTech SE's turn toward oncology treatments has the potential to tap multi-billion-dollar markets in the future Find out why I rate BNTX stock a hold for now
  • BioNTech SE Company Profile - Overview - GlobalData
    BioNTech's product portfolio includes investigational mRNA vaccines, protein-based therapeutics, cell therapies, and small molecules Its first marketed product is Comirnaty The company's products are designed to address the needs of cancer patients and combat infectious diseases




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer